Literature DB >> 8225588

Protective immunity is induced by a Borrelia burgdorferi mutant that lacks OspA and OspB.

C A Hughes1, S M Engstrom, L A Coleman, C B Kodner, R C Johnson.   

Abstract

A mutant of virulent Borrelia burgdorferi 297 was apparently selected for by long-term storage at 5 degrees C. This mutant was found to lack the plasmid which encodes outer surface protein A (OspA) and OspB. In addition to the loss of the OspA and OspB proteins, the mutant lacked two lipoproteins, of 20 and 7.5 kDa, that were observed in the wild type. Since the mutant was not recovered from the tissues or blood of hamsters injected with the mutant, the mutant was determined to be noninfectious. Hamsters vaccinated with noninfectious mutant 297 were protected completely from challenge with virulent wild-type 297 spirochetes. Prechallenge sera from hamsters vaccinated with mutant 297 lacked antibodies to OspA and OspB, while those from hamsters vaccinated with virulent wild-type 297 or avirulent 297 exhibited antibodies to these proteins. Hamsters vaccinated with virulent wild-type 297 or mutant 297 elicited antibodies to OspC and a 39-kDa protein (P39), whereas hamsters vaccinated with avirulent 297 lacked these antibodies. These results suggest that OspC and/or P39 are important for the development of a protective immune response. Study of this mutant may elucidate factors important to the development of a Lyme disease vaccine.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8225588      PMCID: PMC281290          DOI: 10.1128/iai.61.12.5115-5122.1993

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  51 in total

1.  Immunogenicity and efficacy study of a commercial Borrelia burgdorferi bacterin.

Authors:  H J Chu; L G Chavez; B M Blumer; R W Sebring; T L Wasmoen; W M Acree
Journal:  J Am Vet Med Assoc       Date:  1992-08-01       Impact factor: 1.936

2.  Selection of an escape variant of Borrelia burgdorferi by use of bactericidal monoclonal antibodies to OspB.

Authors:  J L Coleman; R C Rogers; J L Benach
Journal:  Infect Immun       Date:  1992-08       Impact factor: 3.441

3.  Heterogeneity of outer membrane proteins in Borrelia burgdorferi: comparison of osp operons of three isolates of different geographic origins.

Authors:  M Jonsson; L Noppa; A G Barbour; S Bergström
Journal:  Infect Immun       Date:  1992-05       Impact factor: 3.441

4.  Experimental Lyme disease in dogs produces arthritis and persistent infection.

Authors:  M J Appel; S Allan; R H Jacobson; T L Lauderdale; Y F Chang; S J Shin; J W Thomford; R J Todhunter; B A Summers
Journal:  J Infect Dis       Date:  1993-03       Impact factor: 5.226

5.  Genetic polymorphism of the gene encoding the outer surface protein A (OspA) of Borrelia burgdorferi.

Authors:  G Zumstein; R Fuchs; A Hofmann; V Preac-Mursic; E Soutschek; B Wilske
Journal:  Med Microbiol Immunol       Date:  1992       Impact factor: 3.402

6.  Molecular analysis of the outer surface protein A (OspA) of Borrelia burgdorferi for conserved and variable antibody binding domains.

Authors:  B Wilske; B Luft; W H Schubach; G Zumstein; S Jauris; V Preac-Mursic; M D Kramer
Journal:  Med Microbiol Immunol       Date:  1992       Impact factor: 3.402

7.  Role of attached lipid in immunogenicity of Borrelia burgdorferi OspA.

Authors:  L F Erdile; M A Brandt; D J Warakomski; G J Westrack; A Sadziene; A G Barbour; J P Mays
Journal:  Infect Immun       Date:  1993-01       Impact factor: 3.441

8.  Examination of Koch's postulates for Borrelia burgdorferi as the causative agent of limb/joint dysfunction in dogs with borreliosis.

Authors:  T L Wasmoen; R W Sebring; B M Blumer; L G Chavez; H J Chu; W M Acree
Journal:  J Am Vet Med Assoc       Date:  1992-08-01       Impact factor: 1.936

9.  Molecular analysis of linear plasmid-encoded major surface proteins, OspA and OspB, of the Lyme disease spirochaete Borrelia burgdorferi.

Authors:  S Bergström; V G Bundoc; A G Barbour
Journal:  Mol Microbiol       Date:  1989-04       Impact factor: 3.501

10.  Antibody-resistant mutants of Borrelia burgdorferi: in vitro selection and characterization.

Authors:  A Sădziene; P A Rosa; P A Thompson; D M Hogan; A G Barbour
Journal:  J Exp Med       Date:  1992-09-01       Impact factor: 14.307

View more
  32 in total

1.  Detection of anti-Borrelia burgdorferi antibody responses with the borreliacidal antibody test, indirect fluorescent-antibody assay performed by flow cytometry, and western immunoblotting.

Authors:  J R Creson; L C Lim; N J Glowacki; S M Callister; R F Schell
Journal:  Clin Diagn Lab Immunol       Date:  1996-03

2.  Resistance to tick-borne spirochete challenge induced by Borrelia burgdorferi strains that differ in expression of outer surface proteins.

Authors:  T J Kurtti; U G Munderloh; C A Hughes; S M Engstrom; R C Johnson
Journal:  Infect Immun       Date:  1996-10       Impact factor: 3.441

3.  Borrelia burgdorferi stimulates the production of interleukin-10 in peripheral blood mononuclear cells from uninfected humans and rhesus monkeys.

Authors:  G H Giambartolomei; V A Dennis; M T Philipp
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

4.  FlaA, a putative flagellar outer sheath protein, is not an immunodominant antigen associated with Lyme disease.

Authors:  Y Ge; N W Charon
Journal:  Infect Immun       Date:  1997-07       Impact factor: 3.441

5.  Differential immune responses to Borrelia burgdorferi in European wild rodent species influence spirochete transmission to Ixodes ricinus L. (Acari: Ixodidae).

Authors:  K Kurtenbach; A Dizij; H M Seitz; G Margos; S E Moter; M D Kramer; R Wallich; U E Schaible; M M Simon
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

6.  The dominant epitope of Borrelia garinii outer surface protein C recognized by sera from patients with neuroborreliosis has a surface-exposed conserved structural motif.

Authors:  M J Mathiesen; A Holm; M Christiansen; J Blom; K Hansen; S Ostergaard; M Theisen
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

7.  Binding of human plasminogen to Borrelia burgdorferi.

Authors:  L T Hu; G Perides; R Noring; M S Klempner
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

8.  Molecular cloning and immunological characterization of a novel linear-plasmid-encoded gene, pG, of Borrelia burgdorferi expressed only in vivo.

Authors:  R Wallich; C Brenner; M D Kramer; M M Simon
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

9.  Phenotypic analysis of outer surface protein C (OspC) of Borrelia burgdorferi sensu lato by monoclonal antibodies: relationship to genospecies and OspA serotype.

Authors:  B Wilske; S Jauris-Heipke; R Lobentanzer; I Pradel; V Preac-Mursic; D Rössler; E Soutschek; R C Johnson
Journal:  J Clin Microbiol       Date:  1995-01       Impact factor: 5.948

10.  Sera from OspA-vaccinated dogs, but not those from tick-infected dogs, inhibit in vitro growth of Borrelia burgdorferi.

Authors:  R K Straubinger; Y F Chang; R H Jacobson; M J Appel
Journal:  J Clin Microbiol       Date:  1995-10       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.